Lack of effect of pioglitazone on postprandial triglyceride levels in type 2 diabetes
- PMID: 11347775
- DOI: 10.2337/diacare.24.5.971
Lack of effect of pioglitazone on postprandial triglyceride levels in type 2 diabetes
Comment on
-
Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.Diabetes Care. 2000 Nov;23(11):1605-11. doi: 10.2337/diacare.23.11.1605. Diabetes Care. 2000. PMID: 11092281 Clinical Trial.
Similar articles
-
Actos (pioglitazone): a new treatment for type 2 diabetes.Hosp Med. 2001 Jul;62(7):411-6. doi: 10.12968/hosp.2001.62.7.1611. Hosp Med. 2001. PMID: 11480129 Review.
-
A comparison in a clinical setting of the efficacy and side effects of three thiazolidinediones.Diabetes Care. 2000 Apr;23(4):557. doi: 10.2337/diacare.23.4.557b. Diabetes Care. 2000. PMID: 10857952 Clinical Trial. No abstract available.
-
Differences in lipid profiles of patients given rosiglitazone followed by pioglitazone.Curr Med Res Opin. 2002;18(6):363-70. doi: 10.1185/030079902125001038. Curr Med Res Opin. 2002. PMID: 12442884
-
Lipid response to pioglitazone in diabetic patients: clinical observations from a retrospective chart review.Diabetes Technol Ther. 2002;4(2):145-51. doi: 10.1089/15209150260007354. Diabetes Technol Ther. 2002. PMID: 12079617
-
[Combination therapy of insulin sensitizer, thiazolidinedione drugs, and sulfonylurea].Nihon Rinsho. 2002 Sep;60 Suppl 9:470-5. Nihon Rinsho. 2002. PMID: 12387036 Review. Japanese. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical